ClinicalTrials.gg
CompletedNCT07507552Updated Nov 17, 2026

Immediate Effects of PETTLEP-Based AOMI on Upper Limb Kinematics in Stroke Survivors

An interventional study of PETTLEP-based Action Observation and Motor Imagery (AOMI) and Cognitive and Somatic Control Tasks in Stroke, Hemiplegia and Hemiplegia and/or Hemiparesis Following Stroke, sponsored by Istinye University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Istinye University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 17, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Stroke by Istinye University — 5 open to participants now, 5 under way, none of them phase 3. Stroke · Istinye University.

Started
2026
with 3 others
No phase
9 of 13
1 open now
Registered
10th of 13
by date

Among the 13 studies in Stroke by Istinye University, this one is one of 4 that started in 2026, is one of 9 with no phase, and was the 10th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

5 of the 13 studies in Stroke by Istinye University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 40 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke by Istinye University, or all of them as a file.
02

Study summary

This study investigates the immediate effects of a single session of Physical, Environment, Task, Timing, Learning, Emotion, Perspective (PETTLEP)-based Action Observation and Motor Imagery (AOMI) on upper-limb movement quality in chronic stroke survivors. Stroke frequently causes reduced movement smoothness and prompts compensatory strategies such as trunk displacement and shoulder elevation. Participants received a single session of either PETTLEP-based AOMI (watching mirror-reversed self-observation and performing real-time kinesthetic imagery of a functional Reach-Drink-Return task) or a duration- and structure-matched active sham (non-motor nature videos and resonant breathing). A single smartphone camera and MediaPipe Pose Landmarker were utilized to evaluate immediate changes in movement smoothness (NVP and SPARC), path straightness, shoulder elevation, trunk displacement, movement time, and functional performance (WMFT-4).

Read the detailed description

This study employs a single-blind, pretest-posttest, prospective randomized controlled trial design to evaluate the acute effects of a single session of Physical, Environment, Task, Timing, Learning, Emotion, Perspective (PETTLEP)-based Action Observation and Motor Imagery (AOMI) in stroke patients. Following a stroke, patients often develop pathological movement patterns and maladaptive compensatory strategies, such as trunk displacement or shoulder girdle elevation, due to impaired motor commands. Traditional task practice requires voluntary motor output that many severely impaired patients lack. Motor imagery combined with action observation offers a cognitive simulation alternative that activates neural motor planning circuits.A total of 28 eligible stroke survivors will be randomized in a 1:1 ratio into an experimental (AOMI) group or a control group. Baseline kinematics of a standardized Reach-to-Drink task will be recorded using MediaPipe, a markerless motion capture system utilizing smartphone cameras.The intervention lasts approximately 13 minutes in total. The experimental group will engage in a scaffolded AOMI protocol. This includes action observation (watching a 1st-person video of the task) and selective motor imagery with specific constraints targeting movement smoothness and the inhibition of compensatory trunk and shoulder movements. The control group will perform matched-duration non-motor mental tasks, focusing on forming mental images that contain no movement, such as calm natural scenes, colors, or light. They will be explicitly instructed to avoid imagining any upper-extremity movements. Immediately following the intervention, the reach-to-drink task will be re-assessed using the MediaPipe system to quantify short-term changes in movement smoothness (Number of Velocity Peaks and Spectral Arc Length - SPARC), trunk displacement, and shoulder girdle elevation.

03

Conditions studied

  • Stroke
  • Hemiplegia
  • Hemiplegia and/or Hemiparesis Following Stroke

Keywords

  • Motor imagery
  • Action observation
  • Stroke
  • Kinematics
  • Upper limb rehabilitation
  • MediaPipe
04

Who can participate

The criteria were revised on the registry on Nov 17, 2026. See what changed

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female and male adults aged 40 to 80 years with a diagnosis of unilateral ischemic or hemorrhagic stroke.
  • A first-ever unilateral ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), or recurrent stroke that left no residual motor deficit from the earlier strokes.
  • Mild to moderate spasticity (Modified Ashworth Scale ≤ 2).
  • Medically stable patients, with no active or uncontrolled systemic illness.
  • Ability to sit unsupported for at least 30 minutes and be able to perform brief cognitive-motor exercises.
  • Able to perform the brief cognitive-motor exercises included in the protocol.
  • Medical Research Council (MRC) muscle strength grade of 3 or higher.

Exclusion criteria

Exclusion Criteria:

  • Time since stroke exceeding 10 years.
  • Other central nervous system disorders (e.g., Parkinson's disease, multiple sclerosis, traumatic brain injury).
  • Musculoskeletal or orthopedic conditions causing restriction of movement in the upper-limb (such as fixed contractures, severe joint deformities, shoulder subluxation).
  • Moderate or severe sensory loss (NIHSS sensory score ≥ 2), or moderate or severe neglect (NIHSS extinction/inattention score ≥ 2).
  • Uncontrolled seizures, severe cardiovascular instability, or any other to imagery.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Experimental Group: PETTLEP-based AOMI

    Participants will receive a single 13-minute session of a scaffolded AOMI protocol. The session includes a preparation phase involving sensory transfer using the unaffected arm, action observation of a 1st-person video, and selective motor imagery with smoothness and trunk control constraints. No physical execution of the task is performed during the intervention.

    Behavioral: PETTLEP-based Action Observation and Motor Imagery (AOMI)

  • Sham comparator
    Control Group: Cognitive and Somatic Control

    A duration-matched 13-minute session comprising non-motor nature footage (beach, forest, waterfall) paired with scene imagery, followed by paced resonant slow breathing (6 breaths/min) using an expanding/contracting visual circle, containing no upper-limb motor content.

    Behavioral: Cognitive and Somatic Control Tasks

Interventions

  • BehavioralPETTLEP-based Action Observation and Motor Imagery (AOMI)

    A mental practice protocol involving sensory preparation (using the unaffected arm to transfer sensation), action observation, and motor imagery of a reach-to-drink task with selective functional constraints targeting movement smoothness, trunk stability, and shoulder control.

  • BehavioralCognitive and Somatic Control Tasks

    Structured non-motor mental tasks, including attention to breathing and calm mental imagery (e.g., natural scenes or colors), timed to match the experimental intervention and explicitly designed to engage attention without any motor system participation.

06

What researchers measure

Primary outcomes

  1. Change in Movement Smoothness (Number of Velocity Peaks)

    Movement smoothness of the affected upper extremity will be quantified as the total Number of Velocity Peaks (NVP) by MediaPipe. Lower NVP values indicate a more continuous movement.

    Time frame: Immediately before and after the 13-minute intervention session.

Secondary outcomes

  1. Movement Smoothness (Spectral Arc Length - SPARC)

    A secondary measure of smoothness calculated using Spectral Arc Length (SPARC) across different phases of the task by MediaPipe. Higher SPARC values indicate smoother movement.

    Time frame: Immediately before and after the 13-minute intervention session.

  2. Path Straightness

    Evaluated as a ratio (0-1) during the reach and reach-to-drink phases. It is calculated by dividing the straight-line distance between the start and end of the wrist path by the total path length travelled. Values closer to 1.0 indicate a straighter, more efficient goal-directed movement path.

    Time frame: Immediately before and after the 13-minute intervention session.

  3. Trunk Displacement (Compensatory Strategy)

    Measured in centimeters (cm) as the maximum anterior horizontal shift of the midpoint between the shoulders in the direction of hand travel from lift onset to the highest wrist point, converted using a participant-specific body-based scale factor. Larger values indicate greater compensatory trunk movement.

    Time frame: Immediately before and after the 13-minute intervention session.

  4. Shoulder Girdle Elevation (Compensatory Strategy)

    Measured in centimeters (cm) as the maximum upward vertical displacement of the affected shoulder in the image plane after lift onset (following median smoothing over a 9-frame window). Larger values reflect greater compensatory shoulder hitching during upper-limb movement.

    Time frame: Immediately before and after the 13-minute intervention session.

  5. Upper-Extremity Function (Wolf Motor Function Test, Short Form - WMFT-4)

    Upper-extremity functional performance will be assessed using the four-item short form of the Wolf Motor Function Test (WMFT-4). Completion time and functional performance scores will be recorded for each item.

    Time frame: Immediately before and after the 13-minute intervention session.

  6. Movement Imagery Ability (Kinesthetic and Visual Imagery Questionnaire-10 - KVIQ-10)

    Evaluates visual and kinesthetic movement-imagery capacity. The visual and kinesthetic subscale scores are summed separately; each ranges from 5 to 25, and the total score ranges from 10 to 50. Higher scores signify greater vividness of imagery.

    Time frame: Immediately before and after the 13-minute intervention session.

  7. Pain - Visual Analog Scale (VAS)

    Participants indicate their pain intensity by placing a mark on a 10-cm horizontal line. The left side is labeled "no pain" (0) and the right side is labeled "worst pain imaginable".

    Time frame: Immediately before and immediately after the 25-minute intervention session.

  8. Visual Analog Mood Scale - 4 dimensions (VAMS-4)

    Evaluates immediate changes in mood state across four dimensions (happy, sad, calm, and tense). Participants rate how they feel at the moment on a 0-10 scale (0 = not at all, 10 = extremely) to control for non-specific emotional responses to the intervention.

    Time frame: Immediately before and after the 13-minute intervention session.

  9. Motor Difference Rating Scale (MDRS)

    A two-item 0-10 self-report scale assessing perceived motor control. Before the intervention, participants rate how well they can control the muscles of the affected arm (0 = no control, 10 = full normal control); immediately after, they rate how much difference they feel in muscle control resulting from the session.

    Time frame: Immediately before and after the 13-minute intervention session.

07

Study locations

2 sites
  • Neurorehabilitation Clinic, Istinye University Liv Bahçeşehir Hospital
    Istanbul, Turkey (Türkiye)
  • Physical Medicine and Rehabilitation Outpatient Clinic, Biruni University Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared to ensure the strict privacy and confidentiality of the stroke survivors participating in this study. The data collected involves specific clinical and kinematic assessments conducted for an academic Master's thesis. The informed consent obtained from participants covers the use of their data for this specific research project and allows for publication in aggregate form only. It does not explicitly grant permission for open public data sharing. Therefore, only summary and aggregate data will be reported in the final thesis and any resulting peer-reviewed publications.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Oct 2026, 5 months.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 5 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 9, 2026: primary completion Mar 2027 → Oct 2026 and completion Mar 2027 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2026
First posted
Apr 2, 2026
StartActual
Apr 10, 2026
Primary completionActual
Oct 5, 2026was Mar 2027
CompletionActual
Oct 5, 2026was Mar 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Nov 9, 2026
Sites
2 sites added — first site in Turkey (Türkiye)
Show 2 added (2 Turkey (Türkiye))
  • Neurorehabilitation Clinic, Istinye University Liv Bahçeşehir Hospital · Istanbul, Turkey (Türkiye)
  • Physical Medicine and Rehabilitation Outpatient Clinic, Biruni University Hospital · Istanbul, Turkey (Türkiye)
Nov 9, 2026
Start date
Apr 1, 2026→Apr 10, 2026 (actual)
Nov 9, 2026
Primary completion
Mar 20, 2027→Oct 5, 2026 (actual)
Nov 9, 2026
Study completion
Mar 20, 2027→Oct 5, 2026 (actual)
Nov 9, 2026
Enrollment
28 (estimated)→24 (actual)
Nov 9, 2026
Eligibility
Criteria revised in 2 updates
What changed on Nov 9, 2026
Inclusion criteria
  • RemovedResidual voluntary movement activity of the affected upper limb.
  • AddedA first-ever unilateral ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), or recurrent stroke that left no residual motor deficit from the earlier strokes.
  • EditedMild to moderate spasticity (Modified Ashworth Scale ≤ 32).
  • RemovedAdequate cognitive function to understand and follow verbal instructions (Mini-Mental State Examination ≥ 21).
  • AddedAble to perform the brief cognitive-motor exercises included in the protocol.
  • AddedMedical Research Council (MRC) muscle strength grade of 3 or higher.
Exclusion criteria
  • RemovedSevere sensory deprivation, visual neglect, or inattention that interferes with completion of the task or the ability to engage in motor imagery.
  • AddedModerate or severe sensory loss (NIHSS sensory score ≥ 2), or moderate or severe neglect (NIHSS extinction/inattention score ≥ 2).
What changed on Nov 17, 2026
Exclusion criteria
  • AddedTime since stroke exceeding 10 years.
across 2 updates, Nov 9, 2026 – Nov 17, 2026
Primary outcomes
1 time frame changed, 1 description edited
What changed in the outcomes
  • Time frameChange in Movement Smoothness (Number of Velocity Peaks)Immediately before the intervention (baseline) and immediately after the single 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
  • DescriptionChange in Movement Smoothness (Number of Velocity Peaks): how it is measured was reworded
Nov 9, 2026
Secondary outcomes
1 edited, 2 time frame changed, 5 added, 1 removed, 2 description edited
What changed in the outcomes
  • EditedMovement Imagery Ability - Movement(Kinesthetic and Visual Imagery Questionnaire-3 (MIQ10 -3 KVIQ-10)Time frame: Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
  • AddedMovement Smoothness (Spectral Arc Length - SPARC)Time frame: Immediately before and after the 13-minute intervention session.
  • AddedPath StraightnessTime frame: Immediately before and after the 13-minute intervention session.
  • AddedUpper-Extremity Function (Wolf Motor Function Test, Short Form - WMFT-4)Time frame: Immediately before and after the 13-minute intervention session.
  • AddedVisual Analog Mood Scale - 4 dimensions (VAMS-4)Time frame: Immediately before and after the 13-minute intervention session.
  • AddedMotor Difference Rating Scale (MDRS)Time frame: Immediately before and after the 13-minute intervention session.
  • RemovedGross Manual Dexterity - Box and Block Test (BBT)Time frame: Immediately before and immediately after the 25-minute intervention session.
  • Time frameShoulder Girdle Elevation (Compensatory Strategy)Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
  • Time frameTrunk Displacement (Compensatory Strategy)Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
  • DescriptionShoulder Girdle Elevation (Compensatory Strategy): how it is measured was reworded
  • DescriptionTrunk Displacement (Compensatory Strategy): how it is measured was reworded
Nov 9, 2026
Show all 2 updates
  1. Nov 17, 2026
    Eligibility 1 exclusion criterion added
    What changed in the criteria
    Exclusion criteria
    • AddedTime since stroke exceeding 10 years.
  2. Nov 9, 2026
    Not yet recruiting→Completed
    2 sites added — first site in Turkey (Türkiye)
    Show 2 added (2 Turkey (Türkiye))
    • Neurorehabilitation Clinic, Istinye University Liv Bahçeşehir Hospital · Istanbul, Turkey (Türkiye)
    • Physical Medicine and Rehabilitation Outpatient Clinic, Biruni University Hospital · Istanbul, Turkey (Türkiye)
    Start date Apr 1, 2026→Apr 10, 2026 (now actual)
    Primary completion Mar 20, 2027→Oct 5, 2026 (now actual)
    Study completion Mar 20, 2027→Oct 5, 2026 (now actual)
    Enrollment 28 (estimated)→24 (actual)
    Eligibility 1 inclusion criterion edited, 3 added, 2 removed; 1 exclusion criterion added, 1 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedResidual voluntary movement activity of the affected upper limb.
    • AddedA first-ever unilateral ischemic or hemorrhagic stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), or recurrent stroke that left no residual motor deficit from the earlier strokes.
    • EditedMild to moderate spasticity (Modified Ashworth Scale ≤ 32).
    • RemovedAdequate cognitive function to understand and follow verbal instructions (Mini-Mental State Examination ≥ 21).
    • AddedAble to perform the brief cognitive-motor exercises included in the protocol.
    • AddedMedical Research Council (MRC) muscle strength grade of 3 or higher.
    Exclusion criteria
    • RemovedSevere sensory deprivation, visual neglect, or inattention that interferes with completion of the task or the ability to engage in motor imagery.
    • AddedModerate or severe sensory loss (NIHSS sensory score ≥ 2), or moderate or severe neglect (NIHSS extinction/inattention score ≥ 2).
    Primary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time frameChange in Movement Smoothness (Number of Velocity Peaks)Immediately before the intervention (baseline) and immediately after the single 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
    • DescriptionChange in Movement Smoothness (Number of Velocity Peaks): how it is measured was reworded
    Secondary outcomes 1 edited, 2 time frame changed, 5 added, 1 removed, 2 description edited
    What changed in the outcomes
    • EditedMovement Imagery Ability - Movement(Kinesthetic and Visual Imagery Questionnaire-3 (MIQ10 -3 KVIQ-10)Time frame: Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
    • AddedMovement Smoothness (Spectral Arc Length - SPARC)Time frame: Immediately before and after the 13-minute intervention session.
    • AddedPath StraightnessTime frame: Immediately before and after the 13-minute intervention session.
    • AddedUpper-Extremity Function (Wolf Motor Function Test, Short Form - WMFT-4)Time frame: Immediately before and after the 13-minute intervention session.
    • AddedVisual Analog Mood Scale - 4 dimensions (VAMS-4)Time frame: Immediately before and after the 13-minute intervention session.
    • AddedMotor Difference Rating Scale (MDRS)Time frame: Immediately before and after the 13-minute intervention session.
    • RemovedGross Manual Dexterity - Box and Block Test (BBT)Time frame: Immediately before and immediately after the 25-minute intervention session.
    • Time frameShoulder Girdle Elevation (Compensatory Strategy)Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
    • Time frameTrunk Displacement (Compensatory Strategy)Immediately before and immediately after the 25-minute intervention session. → Immediately before and after the 13-minute intervention session.
    • DescriptionShoulder Girdle Elevation (Compensatory Strategy): how it is measured was reworded
    • DescriptionTrunk Displacement (Compensatory Strategy): how it is measured was reworded
    + 5 other changes: verification date, description, conditions, arm descriptions and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07507552
Lead sponsor
Istinye University
Responsible party
Abdelrahman Sabee (Physiotherapist and Master's Student, Istinye University) — Principal investigator
First posted
Apr 2, 2026
Start date
Apr 10, 2026
Primary completion
Oct 5, 2026
Completion
Oct 5, 2026
Last update
Nov 17, 2026

Study contacts

Begüm Kara Kaya, Asst. Prof
study director · Istinye University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion